Document Detail

Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide.
MedLine Citation:
PMID:  1578449     Owner:  NLM     Status:  MEDLINE    
Transverse myelitis is a rare but serious complication of systemic lupus erythematosus (SLE). Standard treatment with medium to high doses of oral prednisone has been inadequate to control neurologic sequelae, and patients remain confined to a wheel chair or even die. We employed aggressive treatment in 7 patients with transverse myelitis complicating SLE with pulse methylprednisolone for acute episodes followed by pulse cyclophosphamide for a mean of 6 months; most of our patients are currently able to walk and have partial or total sphincter control.
L Barile; C Lavalle
Related Documents :
19198869 - Intravenous daclizumab for recalcitrant ocular inflammatory disease.
11380039 - Conventional treatment of crohn's disease: objectives and outcomes.
10445599 - Changes in levels of catalase and glutathione in erythrocytes of patients with stable a...
1928879 - A randomized, controlled comparison of isoetharine and albuterol in the treatment of ac...
11772589 - The effect of treatment and its related side effects in patients with severe ocular cic...
19960199 - Successful treatment with rituximab of one patient with canomad neuropathy.
7611119 - Prompt and safe femoral hemostasis with a collagen device after intracoronary implantat...
16364859 - Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial ...
12749789 - Traumatic endophthalmitis following penetrating ocular injuries with retained intraocul...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  19     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  1992 Mar 
Date Detail:
Created Date:  1992-06-10     Completed Date:  1992-06-10     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  370-2     Citation Subset:  IM    
Rheumatic Diseases Unit, Hospital de Especialidades, Centro Medico La Raza, IMSS. Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cyclophosphamide / therapeutic use*
Injections, Intravenous
Lupus Erythematosus, Systemic / complications*,  drug therapy
Methylprednisolone / therapeutic use*
Middle Aged
Myelitis, Transverse / drug therapy,  etiology*
Prednisolone / therapeutic use
Pulsatile Flow
Reg. No./Substance:
50-18-0/Cyclophosphamide; 50-24-8/Prednisolone; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Functional disability in rheumatoid arthritis: two different models in early and established disease...
Next Document:  The arthritis of ulcerative colitis: clinical and genetic aspects.